Different Forms of Prostate-Specific Antigen in Cancer - Mary Heeb

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Cancer Institute (NCI)
Type: First Independent Research Support & Transition (FIRST) Awards (R29)
Project #: 5R29CA059979-04
Application #: 2100589
Study Section: Reproductive Endocrinology Study Section (REN)

Project Start: 1993-05-01
Project End: 1998-04-30
Budget Start: 1996-05-01
Budget End: 1997-04-30
Support Year: 4
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: Scripps Research Institute
Department
Type
DUNS #

City: La Jolla
State: CA
Country: United States
Zip Code: 92037

Related projects


NIH 1998 R29 CA	Different Forms of Prostate Specific Antigen in Cancer Heeb, Mary J. / Scripps Research Institute
NIH 1997 R29 CA	Different Forms of Prostate-Specific Antigen in Cancer Heeb, Mary J. / Scripps Research Institute
NIH 1996 R29 CA	Different Forms of Prostate-Specific Antigen in Cancer Heeb, Mary J. / Scripps Research Institute
NIH 1995 R29 CA	Different Forms of Prostate-Specific Antigen in Cancer Heeb, Mary J. / Scripps Research Institute
NIH 1994 R29 CA	Different Forms of Prostate-Specific Antigen in Cancer Heeb, Mary J. / Scripps Research Institute
NIH 1993 R29 CA	Different Forms of Prostate-Specific Antigen in Cancer Heeb, Mary J. / Scripps Research Institute

Publications

Heeb, M J; Espana, F (1998) alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein. Blood Cells Mol Dis 24:412-9

Comments

Be the first to comment on this grant